HIF1A and diabetes mellitus: Our findings that Lir significantly modulated HIF-1α levels under both normoglycemic and hyperglycemic conditions suggest that the drug may influence cellular responses associated with hypoxic stress, potentially contributing to improved cellular resilience in the context of diabetes.